Diabetes Treatment Devices Market Report 2026
Global Outlook – By Device Type (Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels), By End-User (Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2030
Diabetes Treatment Devices Market Overview
• Diabetes Treatment Devices market size has reached to $12.34 billion in 2025 • Expected to grow to $16.53 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: The Rise In Obesity Rates Drives The Growth Of The Market Due To Increasing Demand For Diabetes Management Solutions • Market Trend: Advancing Automation In Diabetes Care Through Regulatory-Backed Innovations • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Diabetes Treatment Devices Market?
Diabetes treatment devices are medical tools and equipment designed to help manage and treat diabetes by monitoring blood sugar levels, delivering insulin, or assisting with related health needs. These devices enable patients to maintain optimal blood glucose control and reduce complications associated with diabetes. The main device types of diabetes treatment devices are blood glucose monitoring devices, self-monitoring devices, blood glucose meters, testing strips, lancets, continuous glucose monitoring devices, sensors, transmitters, receivers, and other device types. Blood glucose monitoring devices are diabetes treatment tools that measure blood sugar levels to help individuals manage and control their diabetes effectively. These devices are distributed through various channels such as hospital pharmacies, retail pharmacies, diabetes clinics or centers, institutional sales, online pharmacies, and others. They serve a wide range of end users, including hospitals, homecare settings, diagnostic centers, ambulatory surgery centers, and additional healthcare facilities.
What Is The Diabetes Treatment Devices Market Size and Share 2026?
The diabetes treatment devices market size has grown strongly in recent years. It will grow from $12.34 billion in 2025 to $13.11 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to reliance on traditional blood glucose meters, limited awareness of self-monitoring devices, growing hospital and diagnostic center infrastructure, increasing prevalence of diabetes, adoption of standard lancets and testing strips.What Is The Diabetes Treatment Devices Market Growth Forecast?
The diabetes treatment devices market size is expected to see strong growth in the next few years. It will grow to $16.53 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to development of smart insulin pens and pumps, rising adoption of real-time continuous glucose monitoring, integration with smartphones and wearable devices, increasing remote patient monitoring programs, expansion of diabetes clinics and online distribution channels. Major trends in the forecast period include rising adoption of continuous glucose monitoring devices, increasing preference for smart insulin delivery systems, growth in homecare and remote patient monitoring, expansion of wearable and handheld glucometers, rising demand for safety-enhanced lancets and testing strips.
Global Diabetes Treatment Devices Market Segmentation
1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels 3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users Subsegments: 1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices 2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices 3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters 4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips 5) By Lancets: Standard Lancets, Safety Lancets 6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices 7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors 8) By Transmitters: Reusable Transmitters, Disposable Transmitters 9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers 10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin PatchesWhat Is The Driver Of The Diabetes Treatment Devices Market?
The increasing obesity rates are expected to propel the growth of the diabetes treatment devices market in the future. Obesity rate refers to the percentage of individuals classified as obese based on their body mass index (BMI). The increasing obesity rates are primarily due to unhealthy diets high in calories, sugars, and fats, which lead to excessive weight gain when not balanced with physical activity. Diabetes treatment devices help reduce obesity rates by promoting better blood sugar control, which supports healthier lifestyle habits and weight management. For instance, in September 2024, according to the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, in 2023, adult obesity rates reached 35% or higher in 23 US states, up from 22 states in 2022, indicating a worsening obesity trend. Therefore, increasing obesity rates are driving the growth of the diabetes treatment devices industry.Key Players In The Global Diabetes Treatment Devices Market
Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Diabetes Treatment Devices Market Trends and Insights
Major companies operating in the diabetes treatment devices market are focusing on incorporating advanced automation technologies such as automated insulin delivery algorithms to enhance treatment precision and continuous glycemic control. These algorithms use real-time glucose data from continuous glucose monitoring sensors to automatically adjust basal insulin dosing, helping maintain glucose levels within the target range with minimal manual intervention. For instance, in April 2023, Medtronic plc, a US-based medical technology company, received FDA approval for the MiniMed 780G System, an automated insulin delivery technology designed to support individuals with type 1 diabetes by automatically correcting highs and adjusting insulin delivery every five minutes. The system features SmartGuard technology for real-time glucose-responsive insulin adjustments, bluetooth connectivity for mobile monitoring, and integrated continuous glucose monitoring support. The MiniMed 780G System improves treatment accuracy, glucose stability, and day-to-day diabetes management outcomes.What Are Latest Mergers And Acquisitions In The Diabetes Treatment Devices Market?
In September 2023, Abbott Laboratories, a US-based medical device company, acquired Bigfoot Biomedical for an undisclosed amount. With this acquisition, Abbott Laboratories aims to integrate continuous glucose monitoring with smart insulin dosing technology to provide more personalized, connected, and accessible diabetes care. Bigfoot Biomedical Inc. is a US-based medical technology company that develops and provides diabetes treatment devices.
Regional Outlook
North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainNeed data for a specific geography? Request Regional Data
What Defines the Diabetes Treatment Devices Market?
The diabetes treatment devices market consists of sales of smart insulin pens, artificial pancreas systems, closed-loop systems, and jet injectors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Diabetes Treatment Devices Market Report 2026?
The diabetes treatment devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes treatment devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Diabetes Treatment Devices Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $13.11 billion |
| Revenue Forecast In 2030 | $16.53 billion |
| Growth Rate | CAGR of 6% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Device Type, Distribution Channel, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |